ROG
CHF296.90
▲+0.54%
Stock
Roche Holding AG
Official Company Name: Roche Holding AG
Stock Symbol: ROG
Stock Market: Swiss Exchange - SIX
Currency: Swiss franc - CHF
ROG Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▲+27.86%
Daily closing prices, with moving averages and volumes - Swiss franc (CHF)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
Switzerland
Company Description
Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.
ROG Stock Data
| Open | CHF293.50 |
| High | CHF297.10 |
| Low | CHF292.80 |
| Close | CHF296.90 |
| Volume | 1,013,425 |
| Previous Close | CHF295.30 |
| 1-Day Change | 1.60 |
| 1-Year Change | 64.70 |
| Average Daily Volume | 1,244,554 |
| 52-Week High | CHF297.80 |
| 52-Week Low | CHF214.10 |
Ratios as of Jan. 25, 2025
| Beta | 0.15 |
| Trailing PE | 18.67 |
| Forward PE | 12.07 |
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.